Peptide therapy for women: what the science actually supports

What did @hollie_jeanne actually say?

Hollie runs through a four-compound stack she's currently using: GHK-Cu for "hair, skin, nails, collagen, all the pretty things," NAD daily for "brain, energy levels, metabolism," glutathione two to three times a week as a "brilliant detoxifier" that "keeps us glowy," and ipamorelin, which she's just started, taken at night before workouts for growth hormone release, sleep, and skin elasticity. She closes with the standard disclaimer that "all peps are for research purposes only."

That disclaimer matters legally, but it doesn't change what the audience hears. At 63,800 views, this is a functional wellness recommendation, not a lab notebook entry. So let's look at what the evidence actually says about each compound.

Does the science back this up?

Partially, yes. GHK-Cu has the strongest published record of the four. NAD precursors have real data behind them, though "NAD daily" is imprecise. Glutathione's evidence is thinner than its reputation. Ipamorelin's human data is limited and context-dependent.

GHK-Cu (copper peptide) has shown genuine collagen-stimulating activity in fibroblast studies. Pickart and Margolina (2018, Cosmetics) reviewed decades of research showing GHK-Cu upregulates collagen and elastin synthesis and has antioxidant signaling properties. That supports the skin and collagen framing, though "hair and nails" evidence is mostly extrapolated from skin data, not directly studied at the same level.

NAD is where things get murkier. She's likely taking an NAD precursor (NMN or NR) rather than NAD itself, since oral NAD has poor bioavailability. Yoshino et al. (2021, Science) found NMN improved insulin sensitivity in postmenopausal women with prediabetes. Energy and metabolism claims have some backing. Brain claims are emerging but preliminary in humans.

Glutathione IV or liposomal forms have more absorption data than standard oral capsules. The "detoxifier" framing is biologically plausible but oversimplified. Ipamorelin stimulates GH release from the pituitary, but most trials are in surgical or elderly populations, not healthy adults optimizing performance.

What did they get wrong (or right)?

She got GHK-Cu roughly right. The collagen and skin evidence is real, and she didn't overclaim a cure for anything. Credit where it's due.

The ipamorelin framing has problems. Saying she takes it "before her workout" at night is an odd protocol. Ipamorelin is typically used in a fasted state at night specifically to align with the natural GH pulse during sleep. Exercise itself also stimulates GH release. Stacking both simultaneously may create redundancy rather than synergy, and there's no published human data supporting that specific timing for recovery optimization in otherwise healthy adults.

The glutathione claim that it "keeps us fresh, keeps us glowy" is where marketing creep sets in. Weschawalit et al. (2017, Clinical, Cosmetic and Investigational Dermatology) found some skin-lightening effects with oral glutathione, but systemic detoxification claims in healthy people with functioning livers aren't well-supported. The liver and kidneys handle detoxification. Glutathione supplementation supports that system, but calling it a "brilliant detoxifier" implies a level of evidence that isn't quite there yet.

She also never specifies delivery routes. GHK-Cu applied topically behaves very differently from subcutaneous injection. That distinction matters enormously for efficacy and safety, and omitting it leaves viewers to fill in the gaps however they like.

What should you actually know?

These compounds are not equivalent in their evidence base, and treating them as a unified "pep stack" flattens important differences in risk, regulation, and research quality.

GHK-Cu is relatively well-studied and available topically. NAD precursors have emerging metabolic data. Glutathione's oral bioavailability is genuinely debated. Ipamorelin is a prescription-only peptide in most jurisdictions, not a supplement. In the US, it is not FDA-approved for any indication in healthy adults. Compounded ipamorelin exists in a regulatory gray zone, and the FDA has raised concerns about certain compounded peptides in recent years.

The "research purposes only" disclaimer does not make self-administration safe or legal in all contexts. Viewers watching this should know that ipamorelin in particular requires medical supervision, hormonal baseline testing, and monitoring. Growth hormone axis manipulation carries real risks including insulin resistance, edema, and theoretical carcinogenic concerns with long-term use at supraphysiologic levels.

If you are curious about any of these compounds, that conversation belongs with a licensed clinician who can review your labs, not a TikTok comment section.